Distribution of 76 Br-labeled antisense oligonucleotides of different length determined ex vivo in rats

Author： Wu F.   Yngve U.   Hedberg E.   Honda M.   Lu L.   Eriksson B.   Watanabe Y.   Bergstrom M.   Langstrom B.  

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.10, Iss.3, 2000-05, pp. : 179-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-01 ,pp. : 463-470

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular delivery of antisense oligonucleotides

By Lebedeva I.   Benimetskaya L.   Stein C.A.   Vilenchik M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 101-119

Elsevier

Access to resources Recommend Favorite

Antisense oligonucleotides as emerging drugs

By Nyce J.W.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Antisense Oligonucleotides As Therapeutic Agents

By Alama A.   Barbieri F.   Cagnoli M.   Schettini G.  

Pharmacological Research, Vol. 36, Iss. 3, 1997-09 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite

Antisense Oligonucleotides: The State of the Art#

By  

Current Medicinal Chemistry, Vol. 12, Iss. 19, 2005-09 ,pp. : 2193-2214

Bentham Science Publishers

Access to resources Recommend Favorite